These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10655448)

  • 21. Effect of fenretinide on ovarian carcinoma occurrence.
    De Palo G; Mariani L; Camerini T; Marubini E; Formelli F; Pasini B; Decensi A; Veronesi U
    Gynecol Oncol; 2002 Jul; 86(1):24-7. PubMed ID: 12079295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer chemoprevention: additional observations.
    Singh-Ranger G; Mokbel K
    Int J Clin Pract; 2003 Mar; 57(2):155; author reply 155. PubMed ID: 12661805
    [No Abstract]   [Full Text] [Related]  

  • 23. Retinol, vitamins, and cancer prevention: 25 years of learning and relearning.
    Goodman GE; Alberts DS; Meyskens FL
    J Clin Oncol; 2008 Dec; 26(34):5495-6. PubMed ID: 18981460
    [No Abstract]   [Full Text] [Related]  

  • 24. The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients.
    Torrisi R; Pensa F; Orengo MA; Catsafados E; Ponzani P; Boccardo F; Costa A; Decensi A
    Cancer Res; 1993 Oct; 53(20):4769-71. PubMed ID: 8402658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrual.
    De Palo G; Camerini T; Marubini E; Costa A; Formelli F; Del Vecchio M; Mariani L; Miceli R; Mascotti G; Magni A; Campa T; Di Mauro MG; Attili A; Maltoni C; Del Turco MR; Decensi A; D'Aiuto G; Veronesi U
    Tumori; 1997; 83(6):884-94. PubMed ID: 9526578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical development plan: vitamin A.
    J Cell Biochem Suppl; 1996; 26():269-307. PubMed ID: 9154183
    [No Abstract]   [Full Text] [Related]  

  • 27. Translational approaches for the prevention of estrogen receptor-negative breast cancer.
    Li Y; Brown PH
    Eur J Cancer Prev; 2007 Jun; 16(3):203-15. PubMed ID: 17415091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trials reveal no benefit, possible harm of beta carotene and vitamin A for lung cancer prevention.
    Marwick C
    JAMA; 1996 Feb; 275(6):422-3. PubMed ID: 8627947
    [No Abstract]   [Full Text] [Related]  

  • 29. [Breakthrough in breast cancer chemoprevention].
    Kahán Z; Thurzó L
    Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model.
    Rodríguez-Burford C; Lubet RA; Eto I; Juliana MM; Kelloff GJ; Grubbs CJ; Steele VE
    Carcinogenesis; 1999 Jan; 20(1):71-6. PubMed ID: 9934852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic retinoid fenretinide in breast cancer chemoprevention.
    Bonanni B; Lazzeroni M; Veronesi U
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):423-32. PubMed ID: 17428163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakia.
    De Palo G; Veronesi U; Marubini E; Camerini T; Chiesa F; Nava M; Formelli F; Del Vecchio M; Costa A; Boracchi P
    J Cell Biochem Suppl; 1995; 22():11-7. PubMed ID: 8538187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoids for ovarian cancer prevention: laboratory data set the stage for thoughtful clinical trials.
    Veronesi U; Decensi A
    J Natl Cancer Inst; 2001 Apr; 93(7):486-8. PubMed ID: 11287432
    [No Abstract]   [Full Text] [Related]  

  • 35. Breast cancer and fenretinide, an analogue of vitamin A.
    Cobleigh MA
    Leukemia; 1994; 8 Suppl 3():S59-63. PubMed ID: 7808027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventive therapy for breast cancer: a consensus statement.
    Cuzick J; DeCensi A; Arun B; Brown PH; Castiglione M; Dunn B; Forbes JF; Glaus A; Howell A; von Minckwitz G; Vogel V; Zwierzina H
    Lancet Oncol; 2011 May; 12(5):496-503. PubMed ID: 21441069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Love RR
    J Natl Cancer Inst; 1999 Nov; 91(21):1891-2. PubMed ID: 10547398
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Narod S
    J Natl Cancer Inst; 1999 Jan; 91(2):188. PubMed ID: 9923863
    [No Abstract]   [Full Text] [Related]  

  • 39. Specific keynote: chemoprevention of ovarian cancer: the journey begins.
    Ozols RF; Daly MB; Klein-Szanto A; Hamilton TC; Bast RC; Brewer MA
    Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S59-66; discussion S67-70. PubMed ID: 12586088
    [No Abstract]   [Full Text] [Related]  

  • 40. Retinoids as cancer-preventive agents.
    Sankaranarayanan R; Mathew B
    IARC Sci Publ; 1996; (139):47-59. PubMed ID: 8923019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.